Cannabis Bioscience International Holdings, Inc. SEC filings CBIH
Cannabis Bioscience International Holdings, Inc. has 143 filings in SEC EDGAR's recent list, going back to Sep 25, 2007. Its latest annual report, Form 10-K, was filed on Sep 22, 2025 for the period ended May 31, 2025. The latest quarterly report (Form 10-Q) was filed on Apr 16, 2026, covering the quarter ended Feb 28, 2026. The most recent current report (Form 8-K) was filed on Jan 22, 2025 (material agreement). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | 10-q extension for august 2026 | Oct 16, 2026 | Aug 31, 2026 |
| NT 10-K | Form 10-k extension | Aug 31, 2026 | May 31, 2026 |
| 253G2 | Form 253g2 | Jul 1, 2026 | — |
| 253G2 | Form 253g2 | May 21, 2026 | — |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 10-Q | Quarterly report | Apr 16, 2026 | Feb 28, 2026 |
| 253G2 | Form 253g2 | Apr 15, 2026 | — |
| NT 10-Q | Extension | Apr 14, 2026 | Feb 28, 2026 |
| QUALIF | Filing | Apr 13, 2026 | — |
| CORRESP | Letter to the SEC | Apr 8, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2026 | — |
| 1-A | Filing | Mar 27, 2026 | — |
| 10-Q | Quarterly report | Feb 19, 2026 | Nov 30, 2025 |
| NT 10-Q | Extension | Jan 14, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 22, 2025 | Aug 31, 2025 |
| NT 10-Q | Extension | Oct 15, 2025 | Aug 31, 2025 |
| 10-K | Annual report | Sep 22, 2025 | May 31, 2025 |
| NT 10-K | Notification of late filing | Sep 2, 2025 | May 31, 2025 |
| 10-Q/A | Amended quarterly report | May 9, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Apr 22, 2025 | Feb 28, 2025 |
| NT 10-Q | Form 12b-25 | Apr 14, 2025 | Feb 28, 2025 |
| 10-Q/A | Amended quarterly report | Jan 24, 2025 | Nov 30, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2025 | Dec 27, 2024 |
| 10-Q | Quarterly report | Jan 21, 2025 | Nov 30, 2024 |
| NT 10-Q | Form 12b-25 | Jan 13, 2025 | Nov 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 26, 2024 | Nov 22, 2024 |
| 10-Q/A | Amended quarterly report | Oct 31, 2024 | Aug 31, 2024 |
| 10-Q | Quarterly report | Oct 21, 2024 | Aug 31, 2024 |
| NT 10-Q | Extension | Oct 11, 2024 | Aug 31, 2024 |
| 10-K | Annual report | Sep 16, 2024 | May 31, 2024 |
| NT 10-K | Extension for may 2024 | Aug 26, 2024 | May 31, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
|
Aug 22, 2024 | Aug 11, 2024 |
| 10-Q | Quarterly report | Apr 22, 2024 | Feb 29, 2024 |
| NT 10-Q | Extension | Apr 15, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2024 | Mar 14, 2024 |
| 10-Q | Quarterly report | Jan 25, 2024 | Nov 30, 2023 |
| NT 10-Q | Extension | Jan 12, 2024 | Nov 30, 2023 |
| 8-K |
Current report
Other events
|
Dec 14, 2023 | Dec 12, 2023 |
| 424B3 | Prospectus | Dec 6, 2023 | — |
| EFFECT | Filing | Dec 5, 2023 | — |
| CORRESP | Letter to the SEC | Dec 4, 2023 | — |
| CORRESP | Letter to the SEC | Nov 30, 2023 | — |
| S-1/A | Amended registration statement | Nov 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| S-1/A | Amended registration statement | Nov 13, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| S-1/A | Amended registration statement | Sep 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2023 | — |
| CORRESP | Letter to the SEC | Jul 10, 2023 | — |
| S-1/A | Amended registration statement | Jul 10, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| S-1/A | Amended registration statement | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 23, 2023 | — |
| CORRESP | Letter to the SEC | Apr 27, 2023 | — |
| S-1/A | Amended registration statement | Apr 27, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2023 | — |
| S-1/A | Amended registration statement | Jan 13, 2023 | — |
| S-1 | Registration statement | Aug 24, 2022 | — |
| 15-15D | Form 15 | Dec 1, 2015 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 3, 2015 | Feb 20, 2015 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2014 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2013 | — |
| 10-Q | Quarterly report | Apr 20, 2012 | Feb 29, 2012 |
| NT 10-Q | Form nt 10-q | Apr 16, 2012 | Feb 29, 2012 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2012 | — |
| 10-Q | Quarterly report | Jan 23, 2012 | Nov 30, 2011 |
| NT 10-Q | Form nt 10-q | Jan 12, 2012 | Nov 30, 2011 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2011 | Nov 17, 2011 |
| 10-Q/A | Amended quarterly report | Nov 7, 2011 | Aug 31, 2011 |
| 10-Q | Quarterly report | Oct 24, 2011 | Aug 31, 2011 |
| NT 10-Q | Form 12b-25 | Oct 17, 2011 | Aug 31, 2011 |
| 10-K | Annual report | Sep 22, 2011 | May 31, 2011 |
| NT 10-K | Filing | Aug 30, 2011 | May 31, 2011 |
| S-8 | Employee stock plan registration | Jul 26, 2011 | — |
| 10-Q | Quarterly report | May 5, 2011 | Feb 28, 2011 |
| NT 10-Q | Filing | Apr 15, 2011 | Feb 28, 2011 |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2011 | — |
| 10-Q | Quarterly report | Jan 14, 2011 | Nov 30, 2010 |
| 424B3 | Prospectus | Oct 29, 2010 | — |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2010 | Oct 25, 2010 |
| 424B3 | Prospectus | Oct 27, 2010 | — |
| EFFECT | Filing | Oct 26, 2010 | — |
| CORRESP | Letter to the SEC | Oct 26, 2010 | — |
| CORRESP | Letter to the SEC | Oct 15, 2010 | — |
| S-1/A | Amended registration statement | Oct 15, 2010 | — |
| 10-Q | Quarterly report | Oct 15, 2010 | Aug 31, 2010 |
| UPLOAD | Letter from the SEC | Sep 9, 2010 | — |
| S-1/A | Amended registration statement | Aug 30, 2010 | — |
| 10-K | Annual report | Aug 30, 2010 | May 31, 2010 |
| CORRESP | Letter to the SEC | May 25, 2010 | — |
| S-1/A | Amended registration statement | May 25, 2010 | — |
| UPLOAD | Letter from the SEC | May 5, 2010 | — |
| S-1/A | Amended registration statement | Apr 30, 2010 | — |
| 10-Q/A | Amended quarterly report | Apr 27, 2010 | Feb 28, 2010 |
| UPLOAD | Letter from the SEC | Apr 19, 2010 | — |
| 10-Q | Quarterly report | Apr 14, 2010 | Feb 28, 2010 |
| S-1 | Registration statement | Mar 26, 2010 | — |
| 8-K |
Current report
Officer or director change
|
Mar 23, 2010 | Mar 22, 2010 |
| D | Filing | Mar 15, 2010 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Mar 12, 2010 | Mar 11, 2010 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2010 | Feb 12, 2010 |
| UPLOAD | Letter from the SEC | Jan 31, 2010 | — |
| CORRESP | Letter to the SEC | Jan 22, 2010 | — |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2010 | Jan 15, 2010 |
| 8-K |
Current report
Other events
|
Jan 14, 2010 | Jan 14, 2010 |
| 10-Q | Quarterly report | Jan 14, 2010 | Nov 30, 2009 |
| UPLOAD | Letter from the SEC | Jan 13, 2010 | — |
| 8-K |
Current report
Material agreement
|
Jan 6, 2010 | Dec 8, 2009 |
| CORRESP | Letter to the SEC | Dec 28, 2009 | — |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2009 | Dec 17, 2009 |
| D | Filing | Oct 30, 2009 | — |
| D | Filing | Oct 29, 2009 | — |
| 10-Q | Quarterly report | Oct 20, 2009 | Aug 31, 2009 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Oct 20, 2009 | Oct 16, 2009 |
| NT 10-Q | Filing | Oct 16, 2009 | Aug 31, 2009 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2009 | Sep 29, 2009 |
| UPLOAD | Letter from the SEC | Oct 1, 2009 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 29, 2009 | Sep 28, 2009 |
| 10-K | Annual report | Sep 15, 2009 | May 31, 2009 |
| NT 10-K | Filing | Sep 1, 2009 | May 31, 2009 |
| 10-Q/A | Amended quarterly report | May 27, 2009 | Nov 30, 2008 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Apr 29, 2009 | Oct 8, 2008 |
| 10-Q | Quarterly report | Apr 14, 2009 | Feb 28, 2009 |
| 8-K |
Current report
Restatement
|
Apr 13, 2009 | Feb 25, 2009 |
| 8-K |
Current report
Officer or director change
|
Feb 11, 2009 | Feb 6, 2009 |
| 10-Q | Quarterly report | Jan 14, 2009 | Nov 30, 2008 |
| 10-Q | Quarterly report | Nov 18, 2008 | Sep 30, 2008 |
| NT 10-Q | Filing | Nov 17, 2008 | Sep 30, 2008 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2008 | Oct 31, 2008 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Oct 9, 2008 | Oct 8, 2008 |
| 10-Q | Quarterly report | Aug 14, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | May 14, 2008 | Mar 31, 2008 |
| 10KSB | Filing | Mar 28, 2008 | Dec 31, 2007 |
| EFFECT | Filing | Dec 21, 2007 | — |
| CORRESP | Letter to the SEC | Dec 19, 2007 | — |
| SB-2/A | Filing | Dec 19, 2007 | — |
| SB-2/A | Filing | Dec 12, 2007 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2007 | — |
| SB-2 | Filing | Oct 17, 2007 | — |
| REGDEX | Auto-generated paper document | Sep 25, 2007 | — |
Showing 143 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CBIH (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- CO
- Headquarters
- Yantis, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1411057
- Former names
- CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.